Source Profiling of Biohazardous Aerosols in Hospitals
This study has been completed.
Sponsor:
Hospital Authority, Hong Kong
Collaborator:
Hong Kong University of Science and Technology
Information provided by:
Hospital Authority, Hong Kong
ClinicalTrials.gov Identifier:
NCT00517660
First received: August 15, 2007
Last updated: July 21, 2010
Last verified: July 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To characterise the physical parameters (number concentration, size distribution and their trajectories) of aerosols (droplets) generated in high risk procedures.
| Condition |
|---|
|
Respiratory Tract Infections |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Source Profiling of Biohazardous Aerosols in Hospitals |
Further study details as provided by Hospital Authority, Hong Kong:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Sampling Method: | Non-Probability Sample |
Study Population
60 from each groups. Healthy subjects - recruited from voluntary basis. LRTI - recruited from patient wards with consent. URTI - recruited from out-patient clinic with consent.
Criteria
Inclusion Criteria:
- Adult patients (>18 years old) that can give valid consent
- URTI: with symptoms such as coryza, sore throat, nasal discharge, cough and sputum +/- fever. Amongst these, cough should be a major complaint.
- LRTI (CAP): acute lower respiratory illness of no other known cause which is usually associated with fever, symptoms and signs of the chest and abnormalities on the CXR. (BTS 1993).
Exclusion Criteria:
- Pneumonia developed at or after 48 hours, or history of hospital admissions within 1 month of the present admission (to exclude hospital-acquired infections)
- Patients who are unable to cooperate with the study protocols (such as mentally confused, dementia) or are physically unable to sit or stand independently to carry out the tests optimally.
- Patients with TOCC associations with infections such Avian Flu or SARS (travel to endemic areas, at-risk occupations, close contacts with index cases, especially with compatible clinical features) or NPA revealed positivity of influenza A/B
- Patients who are clinically or haemodynamically unstable, such as the need for inotropes, oxygen supplement of >2L/min, any types of shock, etc.
- Underlying diseases that might affect the coughing effort (such as musculoskeletal diseases, or severe kyphoscoliosis)
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00517660
Locations
| China | |
| Queen Elizabeth Hospital | |
| Hong Kong, China | |
Sponsors and Collaborators
Hospital Authority, Hong Kong
Hong Kong University of Science and Technology
Investigators
| Principal Investigator: | Ming Fang, Prof | Institute for the Environment, The Hong Kong University of Science and Technology |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00517660 History of Changes |
| Other Study ID Numbers: | KC/KE-04-0071/ER-1, HARECCTR0500055 |
| Study First Received: | August 15, 2007 |
| Last Updated: | July 21, 2010 |
| Health Authority: | Hong Kong: Ethics Committee |
Keywords provided by Hospital Authority, Hong Kong:
|
Healthy subjects Lower Respiratory Tract Infections Upper Respiratory Tract Infections |
Additional relevant MeSH terms:
|
Respiratory Tract Infections Infection Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 19, 2013